|
業務類別
|
-- |
|
業務概覽
|
Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in the discovery, development manufacturing, and commercialization of biotherapeutics for cancer treatment. Its products pipeline includes various drug candidates such as KN035 (Envida), KN046, KN026, JSKN003, and KN019 among others in different stages of development. |
| 公司地址
| No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215127 |
| 電話號碼
| +86 51262850800 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.alphamabonc.com |
| 員工數量
| 420 |
| Ms. Yang Liu |
Director and Vice President, Corporate Operations |
-- |
28/04/2025 |
| Dr. Ting Xu |
Chairman of the Board and Chief Executive Officer |
-- |
28/04/2025 |
|
|
| Ms. Yang Liu |
Director and Vice President, Corporate Operations |
28/04/2025 |
| Mr. Cheng Kevin Wei |
Independent Director |
28/04/2025 |
| Mr. Dong Wu |
Independent Director |
28/04/2025 |
| Dr. Ting Xu |
Chairman of the Board and Chief Executive Officer |
28/04/2025 |
| Mr. Man Cho |
Director |
28/04/2025 |
| Mr. Zijian Guo |
Independent Director |
28/04/2025 |
|
|
|
|
